These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26649959)

  • 1. [Intensified blood glucose control in type 1 diabetic patients - what are the target levels?].
    Kruithof R; Flatz A; Peytremann-Bridevaux I; Egli M
    Praxis (Bern 1994); 2015 Dec; 104(25):1405-6. PubMed ID: 26649959
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemoglobin A1c in hemodialysis patients: should one size fit all?
    Ix JH
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1539-41. PubMed ID: 20671219
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.
    Williams ME; Lacson E; Wang W; Lazarus JM; Hakim R
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1595-601. PubMed ID: 20671217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A time-limited, problem-orientated psychotherapeutic intervention in Type 1 diabetic patients with complications: a randomized controlled trial.
    Didjurgeit U; Kruse J; Schmitz N; Stückenschneider P; Sawicki PT
    Diabet Med; 2002 Oct; 19(10):814-21. PubMed ID: 12358867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Keller U
    Ther Umsch; 2017; 74(8):454-461. PubMed ID: 29461146
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis.
    Meyer L; Chantrel F; Imhoff O; Sissoko A; Serb L; Dorey F; Fleury D; Smagala A; Kepenekian L; Krummel T; Le Floch JP; Kessler L
    Diabet Med; 2013 Nov; 30(11):1388-9. PubMed ID: 23909880
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreasing frequency of diabetic nephropathy.
    Brouhard BH; Smith D; Ponder SW; Travis LB
    Am J Dis Child; 1988 Nov; 142(11):1138-9. PubMed ID: 3177313
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuous glucose monitoring: long live the revolution!
    Waldron-Lynch F; Herold KC
    Nat Clin Pract Endocrinol Metab; 2009 Feb; 5(2):82-3. PubMed ID: 19092785
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glycaemic control and complications of diabetes: what about?].
    Bouhanick B; Barigou M; Kantambadouno JB; Chamontin B
    Presse Med; 2013 May; 42(5):849-54. PubMed ID: 23540378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis.
    Gallieni M; De Salvo C; Lunati ME; Rossi A; D'Addio F; Pastore I; Sabiu G; Miglio R; Zuccotti GV; Fiorina P
    Acta Diabetol; 2021 Aug; 58(8):975-981. PubMed ID: 33743082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: the "gift" that keeps on giving!
    Cefalu WT; Ratner RE
    Diabetes Care; 2014; 37(1):5-7. PubMed ID: 24356590
    [No Abstract]   [Full Text] [Related]  

  • 12. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
    Bragd J; Adamson U; Bäcklund LB; Lins PE; Moberg E; Oskarsson P
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system.
    Skyler JS
    Diabetes Technol Ther; 2000; 2 Suppl 1():S7-12. PubMed ID: 11469636
    [No Abstract]   [Full Text] [Related]  

  • 14. Kidney disease in diabetology: lessons from 2008.
    Schernthaner G
    Nephrol Dial Transplant; 2009 Feb; 24(2):396-9. PubMed ID: 19144896
    [No Abstract]   [Full Text] [Related]  

  • 15. [Albuminuria in the diabetic patient: practical management].
    Kistler AD
    Praxis (Bern 1994); 2013 Oct; 102(20):1229-35. PubMed ID: 24088233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing or postponing renal disease in insulin-dependent diabetes by glycemic and nonglycemic intervention.
    Mogensen CE; Hansen KW
    Contrib Nephrol; 1990; 78():73-100; discussion 100-1. PubMed ID: 2225845
    [No Abstract]   [Full Text] [Related]  

  • 17. Striving for control: lessons learned from a successful international Type 1 Diabetes Youth Challenge.
    Kordonouri O; Vazeou A; Scharf M; Würsig M; Battelino T;
    Acta Diabetol; 2017 Apr; 54(4):403-409. PubMed ID: 28154987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study.
    Jansson FJ; Forsblom C; Harjutsalo V; Thorn LM; Wadén J; Elonen N; Ahola AJ; Saraheimo M; Groop PH;
    Diabetologia; 2018 May; 61(5):1203-1211. PubMed ID: 29423580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Monitoring of Blood Glucose.
    Garg SK; Hirsch IB
    Diabetes Technol Ther; 2019 Feb; 21(S1):S4-S12. PubMed ID: 30785324
    [No Abstract]   [Full Text] [Related]  

  • 20. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.